Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia.
2021
Abstract Background The efficacy and safety of tofacitinib, a Janus kinase inhibitor, in patients who are hospitalized with coronavirus disease 2019 (Covid-19) pneumonia are unclear. Methods We ran...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
29
References
59
Citations
NaN
KQI